Showing results (701-710 of 2,321) with videos related to

Sort By:
Pageof 233
Journal of Inorganic Biochemistry|March 11, 2006
Genotoxicity and transmission electron microscopy studies of molybdocene dichlorideKate S Campbell, Amalanie J Foster, Carolyn T Dillon, et al.
Eye (London, England)|January 1, 1995
Cataract surgery by junior ophthalmologistsY C Yang, J F Kirwan, P J Foster, et al.
Plos Neglected Tropical Diseases|January 19, 2019
A systematic review and meta-analysis of the prevalence of osteoarticular brucellosisShakirat A Adetunji, Gilbert Ramirez, Margaret J Foster, et al.
Journal of Bacteriology|April 9, 2013
Subdomains N2N3 of fibronectin binding protein A mediate Staphylococcus aureus biofilm formation and adherence to fibrinogen using distinct mechanismsJoan A Geoghegan, Ian R Monk, James P O'Gara, et al.
The Journal of the American Academy of Orthopaedic Surgeons|June 13, 2023
Inflammatory and Immunologic Contributions in Femoroacetabular Impingement SyndromeAdam J Tagliero, Michael J Foster, Heath P Melugin, et al.
Ophthalmology|May 13, 2008
Anterior chamber depth in elderly Chinese: the Liwan eye studyMingguang He, Wenyong Huang, Yingfeng Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 19, 2008
Activation of muscarinic cholinergic receptors on human SH-SY5Y neuroblastoma cells enhances both the influx and efflux of K+ under conditions of hypo-osmolarityDaniel J Foster, Anne M Heacock, Richard F Keep, et al.
Neuropsychiatric Disease and Treatment|February 11, 2014
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophreniaDaniel J Foster, Derrick L Choi, P Jeffrey Conn, et al.
Scientific Reports|November 4, 2018
Genotyping-by-sequencing supports a genetic basis for wing reduction in an alpine New Zealand stoneflyAndrew J Veale, Brodie J Foster, Peter K Dearden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1B J Foster, R A Wiegand, P M LoRusso, et al.
Pageof 233